Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model have?

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model has 97 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model published?

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model has 2010 year in the ScholarIQ index.

What is the open-access status of Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model?

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model has green oa status in the ScholarIQ index.

What is the DOI of Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model?

The DOI for Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model is on the source record.

What is the PMID of Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model?

The PMID for Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model is on the source record.

What is the OpenAlex record for Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model?

The OpenAlex for Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model is on the source record.